Preterm Premature Rupture of Membranes Clinical Trial
Preterm premature rupture of membranes (PPROM) is a complication affecting 3-4.5% of all
pregnancies. PPROM is the main known cause of preterm delivery and is associated worldwide
with increased rates of neonatal and maternal morbidity and mortality. Despite its
frequency, very little is known about its pathophysiologic mechanisms. Mechanical strength
is provided to fetal membranes by an extracellular collagen matrix. Types I, II, III and IV
are the main collagen types in these membranes. Studies have shown that total collagen
content is reduced in the amnion of women with preterm PROM.
Vitamin C is involved in the metabolism of collagen and has been proposed to play an
important role in the maintenance of the integrity of the chorioamniotic membranes. Vitamin
E may play a synergic role with vitamin C, increasing the antioxidant capacity against
reactive oxygen. Woods et al hypothesized that an increase in dietary consumption or
supplementation of vitamin C and E during pregnancy might reduce the risk of that portion of
preterm PROM that may be mediated by oxidative injury to fetal membranes. Plessinger et al
report that pretreatment of human amnion-chorion with vitamins C and E prevents hypochlorous
acid-induced membrane damage.
Borna et al. reported a randomized, double-blind controlled study of vitamin C and E
supplementation, in which women with preterm rupture of membranes and singleton gestations
at 26 to 34 weeks were randomized to vitamin C and E supplementation or placebo.
Supplementation with vitamin C and E were associated with longer latency before delivery.
However, the sample size in this study was very small.
The aim of this study was to evaluate the effect of supplementation with vitamins C and E
after preterm premature rupture of membranes. We hypothesised that supplementation vitamins
C and E may be effective in decreasing oxidative stress and increasing the latency period.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01431248 -
PPROM Erythromycin Versus Azithromycin
|
N/A | |
Active, not recruiting |
NCT04588220 -
Melatonin, Soluble Urokinase-type Plasminogen Activator Receptor, and Orosomucoid 2 Levels in PPROM
|
||
Completed |
NCT02314728 -
Cervical Ripening in Premature Rupture of Membranes
|
N/A | |
Not yet recruiting |
NCT01152528 -
Va-Sense - Bacterial Vaginosis Once A Week Screening And Treatment To Reduce Infective Complications, Abortion And Preterm Delivery In Pregnant Women With Previous Preterm Delivery
|
Phase 3 | |
Completed |
NCT02702297 -
Multimodal Monitoring of Fetal Risk of Inflammation in Preterm Premature Rupture of Membranes
|
||
Not yet recruiting |
NCT02635451 -
The Relation Between Serum Ascorbic Acid Concentration and Preterm Premature Rupture of Membranes
|
N/A | |
Active, not recruiting |
NCT04532021 -
Matrix Metalloproteinase 14, Neopterin, and Orosomucoid 1 Levels in PPROM
|
||
Recruiting |
NCT02548013 -
Preterm Premature Rupture of Membranes, Outpatient Management vs Inpatient Management
|
N/A | |
Recruiting |
NCT01584323 -
Pomegranate to Reduce Maternal and Fetal Oxidative Stress and Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of the Membranes
|
N/A | |
Recruiting |
NCT00466128 -
Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM)
|
Phase 2 | |
Terminated |
NCT00463736 -
Magnesium Sulfate Versus Placebo for Tocolysis in PPROM
|
N/A |